Serum ferritin levels correlate with hypertensive retinopathy

Medical Science Monitor

Volumn 16, Issue 2, 2010, Pages

  Coban, Erkan ^a   Alkan, Erkan ^a   Altuntas, Seher ^a   Akar, Yusuf ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Ferritin; Hypertension; Hypertensive retinopathy; Oxidative stress

Indexed keywords

FERRITIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HYPERTENSION RETINOPATHY; MAJOR CLINICAL STUDY; MALE;

FEMALE; FERRITINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETINAL DISEASES;

EID: 76049129858     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mendes JF, Arruda SF, Siquiera EM et al: Iron status and oxidative stress biomarkers in adults: A preliminary study. Nutrition, 2009; 25: 379-84
2. Marx JJ, Kartikasari AE, Georgiou NA: Can iron chelators influence the progression of atherosclerosis? Hemoglobin, 2008; 32: 123-34
3. Kraml P, Potockova J, Koprivova H et al: Ferritin, oxidative stress and coronary atherosclerosis. Vnitr Lek, 2004; 50: 197-202
4. Ikeda Y, Suehiro T, Yamanaka S et al: Association between serum ferritin and circulating oxidized low-density lipoprotein levels in patients with type 2 diabetes. Endocr J, 2006; 53: 665-70
5. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B: Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J, 1992; 286: 901-5
6. Thong PS, Selley M, Watt F: Elemental changes in atherosclerotic lesion using nuclear microscopy. Cell Mol Biol, 1996; 42: 103-10
7. Abdala DS, Campa A, Monteiro HP: Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis, 1992; 97: 149-59
8. Rajpathak SN, Crandall JP, Wylie-Rosett J et al: The role of iron in type 2 diabetes in humans. Biochim Biphys Acta, 2008; (Epub ahead of print)
9. Sheu WH, Chen YT, Lee WJ et al: A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men. Clin Endocrinol (Oxf), 2003; 58: 380-85
10. Lao TT, Tam KF: Maternal serum ferritin and gestational impaired glucose tolerance. Diabetes Care, 1997; 20: 1368-69
11. Canturk Z, Cetinaraslan B, Tarkun I, Canturk NZ: Serum ferritin levels in poorly- and well-controlled diabetes mellitus. Endocr Res, 2003; 3: 299-306
12. Porta M, Grosso A Veglio F: Hypertensive retinopathy: there's more than meets the eye. J Hypertens, 2005; 23: 683-96
13. Wong TY, McIntosh R: Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull, 2005; 73-74: 57-70
14. Wong TY, Mitchell P: The eye in hypertension. N Engl J Med, 2007; 369: 425-35
15. Dunaief JL: Iron induced oxidative damage as a potential factor in age related macular degeneration: the Cogan Lecture. Invest Ophtalmol Vis Sci, 2006; 47: 4660-64
16. Wong RW, Richa DC, Hahn P et al: Iron toxicity as a potential factor in AMD. Retina, 2007; 27: 997-1003
17. Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their course and prognosis. Am J Med Sci, 1939; 191: 332-43
18. Chobanian AV, Bakris GL, Black HR et al, and National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 Report. JAMA, 2003; 289: 2560-71
19. National Cholesterol Education Program (NCEP) Expert Panel: Summary of the second report of the NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol (Adult Treatment Panel II). JAMA, 1993; 269: 3015-23
20. Friedewald WT, Levi RI, Fredricksen DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972;18: 499-502
21. Baris N, Akdeniz B, Ozerkan F et al: The relationship between hypertensive retinopathy and angiotensin converting enzyme gene polymorphism. Cardiovasc Hematol Disord Drug Targets, 2006; 6: 57-61
22. Yilmaz MI, Sonmez A, Kilic S et al: The association of plasma adiponectin levels with hypertensive retinopathy. Eur J Endocrinol, 2005; 152: 233-40
23. Svardsudd K, Wedel H, Aurell E, Tibblin G: Hypertensive eye ground changes: Prevalence, relation to blood pressure and prognostic importance: The study of men born in 1913. Acta Med Scand, 1978; 204: 159-67
24. Lowenthal MN, Zimlichman R: Resolution of hypertensive retinopathy despite persistent high diastolic pressure. Sout Med J, 1993; 86: 190-93
25. Piperno A, Trombini P, Gelosa M et al: Increased serum ferritin is common in men with essential hypertension. J Hypertens, 2002; 20: 1513-18
26. Minuz P, Patrignani P, Gaino S et al: Determinants of platelet activation in human essential hypertension. Hypertension, 2004; 43: 64-70